Popular COVID-19 conspiracy linked to vaccine 'sensitivity'
A recent study of beliefs and attitudes towards COVID-19 in five different countries (United Kingdom, United States, Ireland, Mexico and Spain) has determined how attractive some important conspiracy theories are to these populations.
The study reveals "key predictors" of susceptibility to fake pandemic news, and finds that a small increase in the perceived reliability of the conspiracy equates to a significant decrease in willingness to vaccinate.
Scientists at the University of Cambridge collected data from national samples in each country and asked participants to rate the reliability of several statements, including the six pandemic myths about COVID-19.
Although the vast majority of people in all five countries/regions considered the misinformation unreliable, the researchers found that certain conspiracy theories had taken root in a large portion of the population.
The entire conspiracy is believed to be most validated by the claim that COVID-19 was designed in the Wuhan laboratory. In the UK and the US, 22-23% of respondents rated this claim as "reliable". In Ireland, the proportion rises to 26 per cent, while in Mexico and Spain it rises to 33 per cent and 37 per cent, respectively.
Participants were asked about their attitudes toward a future coronavirus vaccine. They were also asked to rate the reliability of conspiratorial COVID-19 claims on a scale of 1 to 7.
On average, a one-seventh increase in the reliability of someone's perceived misinformation was associated with a nearly one-fourth (23%) decrease in the likelihood that they would agree to a vaccine.
Similarly, a single-point increase in the Complicity Reliability Scale was associated with a 28% decrease, on average, in the likelihood that someone would recommend vaccination to vulnerable friends and family members.
Conversely, on average, trust in scientists increased by one in seven, resulting in a 73% increase in the likelihood of getting vaccinated, while recommending vaccination to others increased by 79%.
In modelling the level of "vaccine hesitancy", the researchers controlled for many other factors (from age to political factors) and found that the results were consistent for all countries except Spain.
Looking for chemical products? Let suppliers reach out to you!
2026-07-07
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Which Protein Is Present In Covid 19
-
Which Is The Best Covid Vaccine In The World
-
Which Companies Are Making Covid Vaccines
-
Interpretation Of Omicron Covid Variant Symptoms
-
A Look At The Worst Hit Covid Countries
-
The Indian Variant Vaccine Efficacy is only 10%, and it was abandoned by South Africa
-
Compensation Methods For Adverse Reactions To Vaccines In The Post-Epidemic Period
-
Nitric Oxide Nasal Spray Prevents Spread of Coronavirus, Clinical Trials Show
-
'Delta MayJust Be A Warning', New Variant Of COVID-19 May Emerge
-
The Johnson & Johnson Vaccine Is Only 72% Effective, Is It An Inferior Vaccine?
Recommend Reading
-
EFSA Reaffirms Safety of E948 Oxygen and E949 Hydrogen in All Foods No Health Risks Detected
-
Lilly Bets Bigger on China
-
Rising API Costs Threaten Drug Prices
-
Indian Pharma Urges US to Exempt Generics as 50 Percent Tariffs Loom National Security Probe Sparks Supply Fears
-
EFSA Confirms Safety of Vitamin E TPGS as Food Additive New Opinion Covers Multiple Use Levels
-
Sodium Percarbonate: Uses, Benefits, and Safety
-
BASF Opens Up PolyTHF® Technology: A Quiet but Powerful Shake-Up in the Global Fibers Game
-
TBHQ: Uses, Safety, and Health Effects
-
India Issues Final Anti-Dumping Ruling on Chinese TDQ, with Duties Up to US$549 per Ton
-
A $25 Billion “Mega Merger” Is Born: How the AkzoNobel × Axalta Deal Rewrites Global Coatings Power